Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition)
Oral drugs such as ibrutinib play an important role in the treatment of mature B-cell lymphoma (BCL) due to their reliable efficacy, manageable safety, high accessibility, and convenience for use. Still, no guidelines or consensus focusing on oral drug therapies for BCL is available. To provide a re...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510206/ https://www.ncbi.nlm.nih.gov/pubmed/36152123 http://dx.doi.org/10.1007/s11684-021-0891-0 |